Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Mar 6;284(6317):700–702. doi: 10.1136/bmj.284.6317.700

Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia.

D B Freedman, M Shannon, P Dandona, H G Prentice, A V Hoffbrand
PMCID: PMC1496625  PMID: 6802292

Abstract

Nine patients with acute leukaemia developed a complex syndrome of hypocalcaemia and hypomagnesaemia during treatment. These metabolic abnormalities developed rapidly in some patients and gave rise to acute symptoms. Immunoreactive parathormone concentrations in these patients were found to be either absolutely or inappropriately low. Hypomagnesaemia and the action of chemotherapeutic agents, especially adriamycin or cytarabine, or both may have contributed to the pathogenesis of this syndrome.

Full text

PDF
700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chase L. R., Slatopolsky E. Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab. 1974 Mar;38(3):363–371. doi: 10.1210/jcem-38-3-363. [DOI] [PubMed] [Google Scholar]
  2. Hillyard C. J., Oscier D. G., Foa R., Catovsky D., Goldman J. M. Immunoreactive calcitonin in leukaemia. Br Med J. 1979 Dec 1;2(6202):1392–1393. doi: 10.1136/bmj.2.6202.1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Keating M. J., Sethi M. R., Bodey G. P., Samaan N. A. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer. 1977 Apr;39(4):1410–1414. doi: 10.1002/1097-0142(197704)39:4<1410::aid-cncr2820390409>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  4. Lifshitz F., Harrison H. C., Harrison H. E. Response to vitamin D of magnesium deficient rats. Proc Soc Exp Biol Med. 1967 Jun;125(2):472–476. doi: 10.3181/00379727-125-32123. [DOI] [PubMed] [Google Scholar]
  5. Macmanus J., Heaton F. W. The influence of magnesium on calcium release from bone in vitro. Biochim Biophys Acta. 1970 Aug 14;215(2):360–367. doi: 10.1016/0304-4165(70)90035-8. [DOI] [PubMed] [Google Scholar]
  6. Mir M. A., Delamore I. W. Metabolic disorders in acute myeloid leukaemia. Br J Haematol. 1978 Sep;40(1):79–92. doi: 10.1111/j.1365-2141.1978.tb03641.x. [DOI] [PubMed] [Google Scholar]
  7. Reaven E. P., Reaven G. M. A quantitative ultrastructural study of microtubule content and secretory granule accumulation in parathyroid glands of phosphate- and colchicine-treated rats. J Clin Invest. 1975 Jul;56(1):49–55. doi: 10.1172/JCI108078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rude R. K., Oldham S. B., Singer F. R. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 1976 May;5(3):209–224. doi: 10.1111/j.1365-2265.1976.tb01947.x. [DOI] [PubMed] [Google Scholar]
  9. Targovnik J. H., Rodman J. S., Sherwood L. M. Regulation of parathyroid hormone secretion in vitro: quantitative aspects of calcium and magnesium ion control. Endocrinology. 1971 Jun;88(6):1477–1482. doi: 10.1210/endo-88-6-1477. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES